The mortality rate for genitourinary system diseases in the UK is forecasted to decline annually from 12.0 deaths per hundred thousand persons in 2024 to 11.5 in 2028. This represents a continuous downward trend from the actual 2023 mortality rate of 12.0. Notably, the year-on-year reduction between 2024 and 2025 is 1.67%, with smaller annual reductions subsequently. This results in a compound annual growth rate (CAGR) of approximately -1.05% over the five-year forecast period.

Future trends to watch for include:

Advancements in medical technology and treatment options that may further reduce mortality rates.
Public health initiatives targeting early detection and disease management.
Potential impact of socio-economic factors on healthcare access and outcomes.